Three (4%) patients harbored MYC and BCL6 rearrangements, while none exhibited high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements. The gene discussed is BCL2; the disease is B-cell non-Hodgkin lymphoma.